DANIEL EDWARD KREUTZ M.D. NPI 1275789877

NPI Details

Daniel Edward Kreutz, M.D. is a rheumatology internal medicine in Gilbert, AZ with 18 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Daniel Edward Kreutz, M.D. NPI is 1275789877. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2008

The provider's business location address is:

3645 S ROME ST STE 201
GILBERT, AZ
ZIP 85297-338
Phone: (480) 443-8400
Fax: (480) 443-8697

The NPI 1275789877 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Analysis for antibody to coccidioides (bacteria) (HCPCS:86635)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Hepatitis c antibody measurement (HCPCS:86803)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Vitamin d-3 level (HCPCS:82306)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Uric acid level, blood (HCPCS:84550)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Rheumatoid factor level (HCPCS:86431)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Urinalysis, manual test (HCPCS:81002)
• Screening test for autoimmune disorder (HCPCS:86038)
• Total protein level, urine (HCPCS:84156)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Complete ultrasound scan of joint (HCPCS:76881)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Phosphate level (HCPCS:84100)
• Measurement of antibody to noninfectious agent (HCPCS:86256)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Magnesium level (HCPCS:83735)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 8/14/2008 and was last updated on 8/18/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.